Tirzepatide (Mounjaro) KwikPen 7.5 mg

Tirzepatide (Mounjaro) KwikPen 7.5 mg

Mounjaro KwikPen 7.5 mg contains tirzepatide, a prescription medicine administered by subcutaneous injection. Tirzepatide is a dual GIP and GLP-1 receptor agonist used alongside diet and exercise to help improve blood sugar control in adults with type 2 diabetes.

The 7.5 mg dose may be used as a step-up dose after treatment with lower strengths. Dose increases should only be made under the guidance of a qualified healthcare professional.

Important: Prescription medicine. Use only as directed by a healthcare professional. Follow the official product instructions for administration and storage. Common side effects may include nausea, diarrhea, vomiting, decreased appetite, and other gastrointestinal symptoms. Consult your doctor or pharmacist before use.